Cargando…
Neuroprotection of Catalpol for Experimental Acute Focal Ischemic Stroke: Preclinical Evidence and Possible Mechanisms of Antioxidation, Anti-Inflammation, and Antiapoptosis
Neuroprotection is defined as using a therapy that affects the brain tissue in the still-viable ischemic penumbra to salvage or delay the infarction. Catalpol, the main active principle of the root of Radix Rehmanniae, was reported to have pleiotropic neuroprotective effects in neurodegenerative dis...
Autores principales: | Zheng, Xia-wei, Yang, Wen-ting, Chen, Shuang, Xu, Qing-qing, Shan, Chun-shuo, Zheng, Guo-qing, Ruan, Ji-chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530418/ https://www.ncbi.nlm.nih.gov/pubmed/28785376 http://dx.doi.org/10.1155/2017/5058609 |
Ejemplares similares
-
Borneol for Regulating the Permeability of the Blood-Brain Barrier in Experimental Ischemic Stroke: Preclinical Evidence and Possible Mechanism
por: Chen, Zi-xian, et al.
Publicado: (2019) -
Transcriptomic Profiling Reveals the Antiapoptosis and Antioxidant Stress Effects of Fos in Ischemic Stroke
por: Mu, Qiancheng, et al.
Publicado: (2021) -
Neuroprotective Effect of DAHP via Antiapoptosis in Cerebral Ischemia
por: Qin, Yanhua, et al.
Publicado: (2018) -
Astragaloside IV for Experimental Focal Cerebral Ischemia: Preclinical Evidence and Possible Mechanisms
por: Wang, Hui-Lin, et al.
Publicado: (2017) -
Ginsenoside-Rb1 for Ischemic Stroke: A Systematic Review and Meta-analysis of Preclinical Evidence and Possible Mechanisms
por: Shi, Yi-Hua, et al.
Publicado: (2020)